Skip to main content
Main analysis: Extell in the First Quarter: Condo Sales Improve Cash, but Times Square Still Needs Funding
ByMay 29, 2026~7 min read

The Central Park Tower PUT Improves Equity Without Adding Cash

SMI's PUT option can remove up to about $308 million from Extell's current liabilities and lift equity by the same amount, but it does not add cash. The next proof points remain condo cash conversion and binding financing for Times Square.

Extell Limited is heading toward an unusually large balance-sheet improvement: cancelling SMI's PUT option in Central Park Tower could reduce current liabilities by up to about $308 million and increase equity by the same amount as early as the second quarter of 2026. That matters for a company where 42% of liabilities are scheduled to mature within one year under the existing schedules, and where management estimates that the ratio would fall to about 20% after the PUT is cancelled. But this improvement is not a new source of cash. It does not replace condo sales, it does not sign the Times Square construction loan, and it does not by itself change the company's dependence on bank financing and inventory loans. The useful proof is in Smitell II, the entity holding the Series E collateral units: condo sales there already produced $26.6 million of operating cash flow in the quarter, but the cash mainly went to repay an Extell loan rather than remaining as a liquidity cushion. The PUT should therefore be read as a balance-sheet and liability-profile improvement, not as a cash-flow solution. The next proof is twofold: the actual liability reduction in the second quarter, and binding financing agreements for Times Square.

A $308 Million Equity Improvement Does Not Fund the Next Project

The company completed a Central Park Tower refinancing on March 31, 2026 and entered into an approximately $79 million inventory loan tied to 31 condo units that are not part of the Series E collateral units and are not assigned to the project's Class B shares. The loan bears SOFR plus 3.95%, has a two-year term with a one-year extension option, and its proceeds were used to repay the previous loan and will also fund future EB-5 repayments totaling about $18 million.

The more important point is what this financing unlocks in the accounting. Following the refinancing, the company expects to reduce the liability for SMI's PUT option, which sits in current liabilities, by a significant amount and possibly in full. The amount cited is about $308 million, with an equal increase in equity expected during the second quarter.

That can materially change the balance-sheet optics. At March 31, 2026, the company had positive working capital of about $25 million on the consolidated statements, but after twelve-month adjustments it showed an economic working-capital deficit of about $494 million, or about $444 million if EB-5 investor adjustments are included. Management also says the share of liabilities due within less than one year would fall from about 42% to about 20% after the PUT cancellation. Those are material changes, and they can affect how lenders and bondholders view risk.

Still, no cash enters the company from the cancellation itself. The new Central Park Tower loan replaced existing debt and will also serve EB-5 repayments, while the expected PUT reduction is a liability reduction and an equity increase. It can help the financing discussion, but it does not finance the next project by itself.

LayerWhat ImprovesWhat Remains Open
PUT optionA possible reduction of up to about $308 million in current liabilities and a matching equity increaseNo new cash inflow
Liability profileLiabilities due within one year could fall from about 42% to about 20%The company still needs actual refinancing and project funding
Series E collateralThe loan-to-collateral ratio is 49.19% versus an 80% capThe pledged condo units still have no signed sale agreements
Smitell II$26.6 million of operating cash flow in the first quarterQuarter-end cash was only $0.5 million

The Series E Collateral Shows the Gap Between Value and Cash

The Series E collateral detail for Central Park Tower lists 14 condo units with an appraised value of $503.5 million as of March 31, 2026. As of the report date, no sale agreements had been signed for those units. In covenant terms, the position is comfortable: the Series E loan-to-collateral ratio is 49.19%, versus an 80% ceiling. In cash terms, the picture is different. Collateral value and covenant headroom are not the same as signed contracts and collected cash.

Smitell II, the property entity holding the Series E pledged condo units, gives a sharper test. At the end of March 2026 it had $286.8 million of real estate inventory, $244.4 million of liabilities, and $43.7 million of equity. In the first quarter it recorded $46.9 million of revenue, $16.7 million of gross profit, and $26.6 million of operating cash flow. In other words, there are sales and there is cash generation from the condo units.

But that cash did not remain there as surplus liquidity. During the same quarter Smitell II repaid $64.1 million of an Extell loan, paid $9.4 million of interest and loan costs, and ended the period with only $482 thousand of cash. That is not negative by itself, because the entity is built around debt repayment and collateral mechanics. It does show why an equity improvement cannot be treated like available cash. Real cash comes from unit closings, collections, and debt repayment mechanics, not from the mere removal of the PUT liability.

Times Square Still Depends on Binding Agreements

This distinction matters especially because of Times Square Tower. During the reporting period, construction advanced to the 29th floor out of 60 planned floors, in a project with an estimated total budget of about $1.31 billion. The company expects substantial completion in June 2029 and annual NOI of about $250 million to $270 million after stabilization during 2030, but the path there still runs through financing.

The company describes funding through a mix of loans and preferred equity investment, and refers to non-binding memoranda of understanding with an international hotel chain and a banking institution, alongside negotiations with additional banks. It expects to complete those agreements by the end of the second quarter of 2026. In its liquidity analysis, the company is also working to repay about $148 million out of a roughly $208 million loan on the 740 Eighth Avenue and 201 West 54th land parcels through a Times Square construction loan.

The PUT can help indirectly, but it is not a substitute for that step. A lighter-looking balance sheet, higher equity, and fewer short-term liabilities can improve the conversation with lenders. The current ratings also support financing access: Midroog affirmed A3.il on Series D and A2.il on Series E in January 2026 and revised the outlook from negative to stable. But binding financing agreements are a different event from an accounting liability reduction. If those agreements are not signed, the PUT does not close the Times Square funding gap.

The Next Read Depends on Incoming Cash, Not a Liability That Disappears

The right conclusion on the PUT is a large improvement in balance-sheet flexibility, not an immediate improvement in all-in cash flexibility after real cash uses. If the approximately $308 million liability is removed in the second quarter, the company will show stronger equity and a much cleaner short-term liability profile. That can matter for lenders, bondholders, and the company's ability to move through the 2026 financing window. But that value remains mostly accounting-driven until it connects to two things: condo sales that generate cash after debt and collateral requirements, and binding financing agreements that fund the next stage of Times Square. Over the next few quarters, the key is not only whether the PUT cancellation is announced, but what follows it: whether the liability actually falls, whether the short-term liability profile improves, and whether the next project's financing moves from memoranda of understanding to signed agreements.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction